LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVEL OF 5MG/DL WITH ALIROCUMAB THERAPY - HOW LOW IS TOO LOW?

被引：0
|
作者：
Zingas, Nicholas [1 ]
Hussain, Anam [1 ]
Garg, Swapnil [1 ]
Agarwal, Ajay [1 ]
机构：
[1] Dayton Vet Affairs Med Ctr, Dayton, OH USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2785 / 2785
页数：1
相关论文
共 50 条
  • [1] Low-Density Lipoprotein Cholesterol and the On-Target Effects of Therapy How Low Is Too Low?
    Everett, Brendan M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (05) : 483 - 485
  • [2] Alirocumab for low-density lipoprotein cholesterol lowering
    Roth, Eli M.
    FUTURE CARDIOLOGY, 2019, 15 (01) : 17 - 29
  • [3] CONSISTENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL >100/70 MG/DL AT BASELINE
    Robinson, Jennifer
    Schiele, Francois
    Laufs, Ulrich
    Lettino, Maddalena
    Valcheva, Velichka
    Guillonneau, Sophie
    Iorga, Serban R.
    Narcisse, Nadege
    Fox, Keith
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1712 - 1712
  • [4] Threshold level or not for low-density lipoprotein cholesterol
    Barter, PJ
    Sacks, FM
    AMERICAN JOURNAL OF MANAGED CARE, 2001, 7 (05): : S125 - S131
  • [5] Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES
    Goodman, Shaun G.
    Steg, Philippe Gabriel
    Szarek, Michael
    Bhatt, Deepak L.
    Bittner, Vera A.
    Diaz, Rafael
    Harrington, Robert A.
    Jukema, J. Wouter
    White, Harvey D.
    Zeiher, Andreas M.
    Schwartz, Gregory G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (04) : 448 - 451
  • [6] Low-density lipoprotein cholesterol cannot be too low after a myocardial infarction
    Wulff, Anders B.
    Mortensen, Martin B.
    Nordestgaard, Borge G.
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (05) : 540 - 542
  • [7] Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy
    Wiviott, SD
    Cannon, CP
    Morrow, DA
    Ray, KK
    Pfeffer, MA
    Braunwald, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (08) : 1411 - 1416
  • [8] Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL
    Marston, Nicholas A.
    Giugliano, Robert P.
    Park, Jeong-Gun
    Ruzza, Andrea
    Sever, Peter S.
    Keech, Anthony C.
    Sabatine, Marc S.
    CIRCULATION, 2021, 144 (21) : 1732 - 1734
  • [9] Low-Density Lipoprotein Cholesterol: How Low Can We Go?
    Sherbet, Daniel P.
    Garg, Puja
    Brilakis, Emmanouil S.
    Banerjee, Subhash
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (04) : 225 - 232
  • [10] Low-Density Lipoprotein Cholesterol: How Low Can We Go?
    Daniel P. Sherbet
    Puja Garg
    Emmanouil S. Brilakis
    Subhash Banerjee
    American Journal of Cardiovascular Drugs, 2013, 13 : 225 - 232
12345